Subtype
Malignant Female Reproductive System Neoplasm
CI-CAN-00003157Explore in graph →
1,464 active trials11 approved drugs128 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003157Explore in graph →
Clinical trials
6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (740)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04626466 | Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation(MIFADORESOL) | completed | — | 100 | Institut de cancérologie Strasbourg EuropeOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02915523 | Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer | completed | Phase 1 / Phase 2 | 140 | Syndax PharmaceuticalsINDUSTRY |
| 1 |
| Jan 10, 2024 |
| clinicaltrials |
| NCT05213078 | Family Caregivers in Underserved Populations Providing Complex Cancer Care | completed | N/A | 48 | City of Hope Medical CenterOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT03219268 | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms | completed | Phase 1 | 277 | MacroGenicsINDUSTRY | 8 | Dec 21, 2023 | clinicaltrials |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | completed | Phase 1 | 117 | Corvus Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 21, 2023 | clinicaltrials |
| NCT04168242 | Scalp Cooling in Gynecologic Cancer Patients | completed | N/A | 80 | The University of Hong KongOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT06177236 | Clinic or Self-Sampling for Cervical Cancer Screening | completed | N/A | 110 | Istanbul University - CerrahpasaOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT04590599 | A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy | completed | Phase 2 | 205 | Innovent Biologics (Suzhou) Co. Ltd.INDUSTRY | 1 | Dec 18, 2023 | clinicaltrials |
| NCT04284852 | Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting(NEOPRIMA) | completed | Phase 2 | 20 | The University of Hong KongOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT04405349 | Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer | completed | Phase 2 | 52 | Nykode Therapeutics ASAINDUSTRY | 6 | Dec 15, 2023 | clinicaltrials |
| NCT03211481 | Design of an Intra-operative Blood Conservation Pathway at Open Myomectomy | completed | — | 24 | Unity Health TorontoOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT01402271 | Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | completed | Phase 1 / Phase 2 | 88 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Dec 11, 2023 | clinicaltrials |
| NCT02413606 | ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?(ENSURE) | completed | N/A | 319 | Comprehensive Cancer Centre The NetherlandsOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT04262089 | Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study(PAM) | completed | Phase 1 | 10 | University Medical Center GroningenOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT02503436 | C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population(C-PATROL) | completed | — | 276 | AstraZenecaINDUSTRY | 1 | Dec 4, 2023 | clinicaltrials |
| NCT06082505 | Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 1(SEMM1) | completed | N/A | 8,262 | The University of Texas Health Science Center, HoustonOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT03367923 | Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors | completed | Phase 2 | 47 | Stanford UniversityOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT06148129 | Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients | completed | N/A | 96 | Zagazig UniversityOTHER_GOV | 1 | Nov 28, 2023 | clinicaltrials |
| NCT02567253 | Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer(OvIP1) | completed | Phase 2 | 56 | University Hospital, GhentOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT05372016 | Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Nov 24, 2023 | clinicaltrials |
| NCT06145295 | The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life | completed | N/A | 68 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT04593550 | Electroencephalographic Changes Under General Anesthesia in Patients With Gynecologic Cancers With and Without History of Chemotherapy | completed | — | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT03784677 | A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors | completed | Phase 1 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT04474184 | Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates | completed | Phase 1 | 33 | Mayo ClinicOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06115577 | Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes | completed | — | 92 | Pirogov Russian National Research Medical UniversityOTHER | 0 | Nov 15, 2023 | clinicaltrials |
| NCT02498665 | A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies | completed | Phase 1 | 24 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Nov 14, 2023 | clinicaltrials |
| NCT02729298 | First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors | completed | Phase 1 | 177 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Nov 14, 2023 | clinicaltrials |
| NCT04563130 | Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer | completed | N/A | 91 | Duke UniversityOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT00716976 | Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy | completed | Phase 3 | 131 | Children's Oncology GroupNETWORK | 3 | Nov 9, 2023 | clinicaltrials |
| NCT03304210 | PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer(PIPAC-nabpac) | completed | Phase 1 | 20 | University Hospital, GhentOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT04286243 | Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi | completed | N/A | 8,174 | University of North Carolina, Chapel HillOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT02864277 | Enhanced Recovery After Surgery Gynecology Oncology(ERAS) | completed | N/A | 120 | Northwestern UniversityOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT03840200 | A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. | completed | Phase 1 | 51 | Hoffmann-La RocheINDUSTRY | 5 | Oct 30, 2023 | clinicaltrials |
| NCT05986266 | Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss | completed | Phase 1 | 62 | EgymedicalpediaINDUSTRY | 1 | Oct 17, 2023 | clinicaltrials |
| NCT02477202 | Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation | completed | N/A | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT03364673 | Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer | completed | N/A | 29 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT04426019 | Using a Lay Health Worker Program to Increase Breast and Cervical Cancer Screening in Low-Income Hispanic Women | completed | N/A | 1,025 | The University of Texas Health Science Center, HoustonOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT04852471 | Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging | completed | N/A | 102 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT05027490 | CAncer, NUtrition and Taste 2(CANUT-2) | completed | N/A | 209 | Hospices Civils de LyonOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT02897375 | Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors | completed | Phase 1 | 71 | Emory UniversityOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT04534309 | Behavioral Weight Loss Program for Cancer Survivors in Maryland(ASPIRE) | completed | N/A | 340 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT00066729 | Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT00072410 | Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer | completed | Phase 1 | 7 | Ludwig Institute for Cancer ResearchOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT00112957 | Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer | completed | Phase 2 | 23 | Ludwig Institute for Cancer ResearchOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT00803569 | Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers | completed | Phase 1 | 13 | Ludwig Institute for Cancer ResearchOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT04021459 | Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery.(E-CTC) | completed | N/A | 15 | University Hospital, MontpellierOTHER | 1 | Oct 3, 2023 | clinicaltrials |
| NCT02744898 | A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus | completed | Phase 2 | 23 | NYU Langone HealthOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT01357161 | A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) | completed | Phase 2 | 136 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 21, 2023 | clinicaltrials |
| NCT06047730 | Clinical Effect Evaluation of Laparoscopic Surgery for Ovarian Benign Tumors by Different Approaches | completed | — | 173 | Yingchun MaOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT04679675 | Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial(STEP) | completed | N/A | 32,771 | Kaiser PermanenteOTHER | 1 | Sep 18, 2023 | clinicaltrials |
Data updated 24 days agoSource updated Jan 11, 2024source: clinicaltrials